AbbVie Inc. (LON:0QCV)

AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of GBP 306.63 billion. The enterprise value is 354.24 billion.

Market Cap	306.63B
Enterprise Value	354.24B

Important Dates

The next estimated earnings date is Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	Jul 15, 2025

Share Statistics

Current Share Class	1.77B
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.76B

Valuation Ratios

The trailing PE ratio is 112.84 and the forward PE ratio is 17.74.

PE Ratio	112.84
Forward PE	17.74
PS Ratio	7.20
PB Ratio	-3,044.16
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.80, with an EV/FCF ratio of 26.61.

EV / Earnings	130.36
EV / Sales	8.18
EV / EBITDA	16.80
EV / EBIT	24.11
EV / FCF	26.61

Financial Position

The company has a current ratio of 0.74

Current Ratio	0.74
Quick Ratio	0.48
Debt / Equity	n/a
Debt / EBITDA	2.48
Debt / FCF	3.87
Interest Coverage	6.92

Financial Efficiency

Return on equity (ROE) is 112.85% and return on invested capital (ROIC) is 16.70%.

Return on Equity (ROE)	112.85%
Return on Assets (ROA)	8.87%
Return on Invested Capital (ROIC)	16.70%
Return on Capital Employed (ROCE)	20.33%
Revenue Per Employee	774,066
Profits Per Employee	49,408
Employee Count	55,000
Asset Turnover	0.42
Inventory Turnover	3.65

Taxes

Income Tax	-540.86M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.44% in the last 52 weeks. The beta is 0.53, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	+23.44%
50-Day Moving Average	210.64
200-Day Moving Average	194.80
Relative Strength Index (RSI)	69.65
Average Volume (20 Days)	4,606

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.05

Income Statement

In the last 12 months, AbbVie had revenue of GBP 42.57 billion and earned 2.72 billion in profits. Earnings per share was 1.53.

Revenue	42.57B
Gross Profit	30.33B
Operating Income	14.45B
Pretax Income	2.21B
Net Income	2.72B
EBITDA	20.49B
EBIT	14.45B
Earnings Per Share (EPS)	1.53

Balance Sheet

The company has 4.72 billion in cash and 51.52 billion in debt, giving a net cash position of -46.80 billion.

Cash & Cash Equivalents	4.72B
Total Debt	51.52B
Net Cash	-46.80B
Net Cash Per Share	n/a
Equity (Book Value)	-100.73M
Book Value Per Share	-0.08
Working Capital	-7.67B

Cash Flow

In the last 12 months, operating cash flow was 14.07 billion and capital expenditures -762.02 million, giving a free cash flow of 13.31 billion.

Operating Cash Flow	14.07B
Capital Expenditures	-762.02M
Free Cash Flow	13.31B
FCF Per Share	n/a

Margins

Gross margin is 71.25%, with operating and profit margins of 33.95% and 6.45%.

Gross Margin	71.25%
Operating Margin	33.95%
Pretax Margin	5.19%
Profit Margin	6.45%
EBITDA Margin	48.13%
EBIT Margin	33.95%
FCF Margin	31.27%

Dividends & Yields

This stock pays an annual dividend of 4.99, which amounts to a dividend yield of 2.06%.

Dividend Per Share	4.99
Dividend Yield	2.06%
Dividend Growth (YoY)	2.51%
Years of Dividend Growth	10
Payout Ratio	301.30%
Buyback Yield	-0.03%
Shareholder Yield	2.03%
Earnings Yield	0.89%
FCF Yield	4.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.14 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.14
Piotroski F-Score	6